Kilitch Drugs (India) Limited (KILITCH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-66.20 Million ≈ $-715.95K USD) by net assets (Rs2.64 Billion ≈ $28.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kilitch Drugs (India) Limited balance sheet quality to measure how much of total assets are equity-financed.
Kilitch Drugs (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check KILITCH cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tecnotree Oyj
HE:TEM1V
|
0.035x |
|
Technology & Telecommunication
NASDAQ:TETE
|
0.010x |
|
Anfield Energy Inc.
NASDAQ:AEC
|
-0.070x |
|
Altenergy Acquisition Corp
NASDAQ:AEAE
|
0.017x |
|
GaeaSoft Corp
KQ:051160
|
0.074x |
|
Interpark Co. Ltd
KQ:035080
|
0.004x |
|
Magna Prima Bhd
KLSE:7617
|
0.138x |
|
Taekyung BK Co Ltd
KO:014580
|
0.037x |
Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see KILITCH market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.00 Billion ≈ $21.68 Million |
Rs175.42 Million ≈ $1.90 Million |
0.088x | +10608.11% |
| 2024-03-31 | Rs1.76 Billion ≈ $19.00 Million |
Rs-1.46 Million ≈ $-15.82K |
-0.001x | -104.85% |
| 2023-03-31 | Rs1.51 Billion ≈ $16.28 Million |
Rs25.86 Million ≈ $279.64K |
0.017x | -58.34% |
| 2022-03-31 | Rs1.40 Billion ≈ $15.17 Million |
Rs57.83 Million ≈ $625.41K |
0.041x | -88.31% |
| 2021-03-31 | Rs1.29 Billion ≈ $14.00 Million |
Rs456.59 Million ≈ $4.94 Million |
0.353x | +1034.35% |
| 2020-03-31 | Rs1.20 Billion ≈ $13.03 Million |
Rs37.45 Million ≈ $405.02K |
0.031x | +1216.09% |
| 2019-03-31 | Rs1.23 Billion ≈ $13.32 Million |
Rs2.91 Million ≈ $31.46K |
0.002x | -81.28% |
| 2018-03-31 | Rs1.13 Billion ≈ $12.19 Million |
Rs14.23 Million ≈ $153.90K |
0.013x | +13.89% |
| 2017-03-31 | Rs1.01 Billion ≈ $10.94 Million |
Rs11.21 Million ≈ $121.28K |
0.011x | -93.01% |
| 2016-03-31 | Rs1.09 Billion ≈ $11.75 Million |
Rs172.33 Million ≈ $1.86 Million |
0.159x | +349.49% |
| 2015-03-31 | Rs1.20 Billion ≈ $12.96 Million |
Rs-76.18 Million ≈ $-823.90K |
-0.064x | +75.42% |
| 2014-03-31 | Rs1.20 Billion ≈ $13.00 Million |
Rs-310.84 Million ≈ $-3.36 Million |
-0.259x | -2155.68% |
| 2013-03-31 | Rs1.19 Billion ≈ $12.88 Million |
Rs14.97 Million ≈ $161.93K |
0.013x | +104.95% |
| 2012-03-31 | Rs1.16 Billion ≈ $12.50 Million |
Rs-293.49 Million ≈ $-3.17 Million |
-0.254x | -217.16% |
| 2011-03-31 | Rs858.72 Million ≈ $9.29 Million |
Rs186.05 Million ≈ $2.01 Million |
0.217x | +3.92% |
| 2010-03-31 | Rs740.88 Million ≈ $8.01 Million |
Rs154.46 Million ≈ $1.67 Million |
0.208x | +27.83% |
| 2009-03-31 | Rs643.97 Million ≈ $6.96 Million |
Rs105.03 Million ≈ $1.14 Million |
0.163x | +120.74% |
| 2008-03-31 | Rs513.18 Million ≈ $5.55 Million |
Rs-403.48 Million ≈ $-4.36 Million |
-0.786x | -189.85% |
| 2007-03-31 | Rs135.84 Million ≈ $1.47 Million |
Rs118.87 Million ≈ $1.29 Million |
0.875x | +22.51% |
| 2006-03-31 | Rs116.74 Million ≈ $1.26 Million |
Rs83.39 Million ≈ $901.79K |
0.714x | -- |
About Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, ant… Read more